These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 2949057)

  • 21. On acute and chronic CNS effects of antidepressants in normals: neurophysiological, behavioral and pharmacokinetic studies with pirlindol.
    Saletu B; Grünberger J
    Methods Find Exp Clin Pharmacol; 1985 Mar; 7(3):137-51. PubMed ID: 4010387
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Psychophysiological and psychometric studies after manipulating the GABA system by vigabatrin, a GABA-transaminase inhibitor.
    Saletu B; Grünberger J; Linzmayer L; Schwartz JJ; Haegele KD; Schechter PJ
    Int J Psychophysiol; 1986 May; 4(1):63-80. PubMed ID: 3721943
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Functional improvement of the aging brain: placebo controlled pharmaco-EEG and psychometric studies with a metabolically active hemoderivative (Actovegin)].
    Saletu B; Grünberger J; Linzmayer L; Stöhr H
    Z Gerontol; 1984; 17(5):271-9. PubMed ID: 6395527
    [TBL] [Abstract][Full Text] [Related]  

  • 24. EEG brain mapping in evaluating the time-course of the central action of DUP 996--a new acetylcholine releasing drug.
    Saletu B; Darragh A; Salmon P; Coen R
    Br J Clin Pharmacol; 1989 Jul; 28(1):1-16. PubMed ID: 2775607
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Double-blind, placebo-controlled pharmacodynamic studies with a nutraceutical and a pharmaceutical dose of ademetionine (SAMe) in elderly subjects, utilizing EEG mapping and psychometry.
    Arnold O; Saletu B; Anderer P; Assandri A; di Padova C; Corrado M; Saletu-Zyhlarz GM
    Eur Neuropsychopharmacol; 2005 Oct; 15(5):533-43. PubMed ID: 16046102
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Early clinical pharmacological trials with a new anti-epileptic, milacemide, using pharmaco-EEG and psychometry.
    Saletu B; Grünberger J
    Methods Find Exp Clin Pharmacol; 1984 Jun; 6(6):317-30. PubMed ID: 6431211
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetic and -dynamic studies with a new anxiolytic, suriclone, utilizing EEG mapping and psychometry.
    Saletu B; Grünberger J; Linzmayer L; Semlitsch HV; Anderer P; Chwatal K
    Br J Clin Pharmacol; 1994 Feb; 37(2):145-56. PubMed ID: 7910470
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Double-blind comparisons of a selective serotonin reuptake inhibitor, zimelidine, and placebo on quantified EEG parameters and psychological variables.
    Schenk GK; Filler W; Ranft W; Zerbin D
    Acta Psychiatr Scand Suppl; 1981; 290():303-13. PubMed ID: 6452797
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Psychopharmacological effects of sertraline in normal, healthy volunteers.
    Hindmarch I; Bhatti JZ
    Eur J Clin Pharmacol; 1988; 35(2):221-3. PubMed ID: 3191944
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Objective measures in determining the central effectiveness of a new antihypoxidotic SL-76188: pharmaco-EEG, psychometric and pharmacokinetic analyses in the elderly.
    Grünberger J; Saletu B; Linzmayer L; Stöhr H
    Arch Gerontol Geriatr; 1982 Nov; 1(3):261-85. PubMed ID: 6764605
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmaco-EEG profiles of antidepressants. Pharmacodynamic studies with fluvoxamine.
    Saletu B; Grünberger J; Rajna P
    Br J Clin Pharmacol; 1983; 15 Suppl 3(Suppl 3):369S-383S. PubMed ID: 6407499
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The pharmacokinetics of nomifensine. Comparison of pharmacokinetics and pharmacodynamics using computer pharmaco-EEG.
    Saletu B; Grünberger J; Linzmayer L; Taeuber K
    Int Pharmacopsychiatry; 1982; 17 Suppl 1():43-72. PubMed ID: 7129805
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Determination of pharmacodynamics of the new neuroleptic zetidoline by neuroendocrinologic, pharmaco-EEG, and psychometric studies--Part I.
    Saletu B; Grünberger J; Linzmayer L; Dubini A
    Int J Clin Pharmacol Ther Toxicol; 1983 Oct; 21(10):489-95. PubMed ID: 6139346
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of the novel neuroprotective agent, riluzole, on human brain function and behavior: I. Double-blind, placebo-controlled EEG mapping and psychometric studies under normoxia.
    Saletu B; Grünberger J; Anderer P; Linzmayer L
    Methods Find Exp Clin Pharmacol; 1996; 18(1):55-66. PubMed ID: 8721257
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Absence of effect of sertraline on the pharmacokinetics and pharmacodynamics of phenytoin.
    Rapeport WG; Muirhead DC; Williams SA; Cross M; Wesnes K
    J Clin Psychiatry; 1996; 57 Suppl 1():24-8. PubMed ID: 8617708
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Double-blind, placebo-controlled quantitative EEG and psychometric studies in elderlies on vigilance-promoting effects of an almitrine/raubasine combination (Duxil).
    Saletu B; Grünberger J; Linzmayer L; Anderer P
    Arch Gerontol Geriatr; 1988 Jun; 7(2):93-110. PubMed ID: 3415398
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acute effects of sertraline, amitriptyline, and placebo on the psychomotor performance of healthy subjects over 50 years of age.
    Mattila MJ; Saarialho-Kere U; Mattila M
    J Clin Psychiatry; 1988 Aug; 49 Suppl():52-8. PubMed ID: 3045113
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical implications of the pharmacology of sertraline.
    Warrington SJ
    Int Clin Psychopharmacol; 1991 Dec; 6 Suppl 2():11-21. PubMed ID: 1806626
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sertraline, 1S,4S-N-methyl-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthylamine, a new uptake inhibitor with selectivity for serotonin.
    Koe BK; Weissman A; Welch WM; Browne RG
    J Pharmacol Exp Ther; 1983 Sep; 226(3):686-700. PubMed ID: 6310078
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Visualizing central effects of S-adenosyl-L-methionine (SAMe), a natural molecule with antidepressant properties, by pharmaco-EEG mapping.
    Saletu-Zyhlarz GM; Anderer P; Linzmayer L; Semlitsch HV; Assandri A; Prause W; Hassan Abu-Bakr M; Lindeck-Pozza E; Saletu B
    Int J Neuropsychopharmacol; 2002 Sep; 5(3):199-215. PubMed ID: 12366873
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.